Breast Cancer Program
Breast Cancer Program
Breast Cancer Program
Cardio-Oncology Program
This study evaluates the preliminary efficacy and safety of NIS793 and other novel investigational combinations with SOC anti-cancer therapy vs SOC anti-cancer therapy for the second line treatment of metastatic colorectal cancer.
Radiation Oncology
Patient and Family Services During Cancer Care